The dysregulated expression of SOX2 has been implicated in various cancer types, and research studies have demonstrated that SOX2 exerts a positive influence on key characteristics of cancer cells, including proliferation, migration, invasion, and metastasis. In addition, SOX2 mediates resistance to existing cancer therapies and is expressed in CSCs. The gene discussed is SOX2; the disease is cancer.